Cargando…
How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic Approach
Depression is the single largest contributor to non-fatal health loss and affects 322 million people globally. The clinical heterogeneity of this disorder shows biological correlates and it makes the personalization of antidepressant prescription an important pillar of treatment. There is increasing...
Autores principales: | Fabbri, Chiara, Serretti, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609216/ https://www.ncbi.nlm.nih.gov/pubmed/33124583 http://dx.doi.org/10.9758/cpn.2020.18.4.484 |
Ejemplares similares
-
Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future
por: Fabbri, Chiara, et al.
Publicado: (2020) -
Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment
por: Fabbri, Chiara, et al.
Publicado: (2020) -
Step up, step back: how to really deliver strategic change in your organization
por: Johnson, Elsbeth
Publicado: (2020) -
Clinical Utility of Fluid Biomarker in Depressive Disorder
por: Serretti, Alessandro
Publicado: (2022) -
Viewpoint : Strategic step for medical impact
por: Bordry, Frédérick
Publicado: (2018)